CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 500 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05787522
NCT05787522N/ACompleted

Prospective, Multicenter, Randomized Evaluation of the Performance and Clinical Applicability of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk

Tianjin Medical University Cancer Institute and Hospital·observational·Posted Mar 28, 2023·Updated Feb 12, 2026

In Brief

An observational study for Lung Cancer and 2 related conditions. Completed, enrolled 500 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to evaluate performance and clinical applicability of AI-assisted radiotherapy contouring software (iCurveE) for thoracic organs at risk. The main question it aims to answer is: • Does AI-assisted contouring (AI contouring with manual modification) offer greater accuracy and time efficiency compared to manual contouring? After screening, the qualified participants' thoracic CT images will be anonymized and segmented using three methods: manual, AI (AI-only), and AI-assisted contouring. The researchers will compare the results generated by the three different contouring methods with the ground truth established by expert consensus, in order to evaluate both accuracy and time-related parameters

Study Details

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 28, 2023
Enrollment StartSep 30, 2022
Primary CompletionJul 27, 2023
Study CompletionMar 6, 2024
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 3.3 years ago